If you’ve researched IVF risks at all, you’ve probably come across ovarian hyperstimulation syndrome, or OHSS - and it can sound alarming. The good news is that OHSS is largely preventable with the right protocol choice, and it’s exactly the kind of risk that thoughtful, individualized stimulation is designed to manage from the very first injection.

What Is OHSS?

Ovarian hyperstimulation syndrome occurs when the ovaries respond too strongly to fertility medications used to stimulate egg production, becoming swollen and, in more significant cases, leaking fluid into the abdomen. Mild OHSS is relatively common and usually resolves on its own with rest and hydration. Moderate to severe OHSS is far less common but can require closer medical monitoring or, in rare cases, hospitalization.

Who Is Most at Risk for OHSS?

A few factors are consistently associated with higher OHSS risk:

• High antral follicle count and high ovarian reserve - patients with many follicles available to respond to stimulation are more prone to an exaggerated response.
• PCOS (polycystic ovary syndrome) - one of the most well-established risk factors for OHSS, given the naturally higher follicle count associated with the condition.
• Younger patients, who often have a stronger baseline ovarian response to stimulation medication.
• Prior history of OHSS in an earlier cycle, which meaningfully raises the risk in subsequent cycles if the same protocol approach is used again.
• High or rapidly rising estradiol levels during stimulation monitoring, which can signal an outsized response before it becomes clinically significant.

A 2022 Scientific reports comparing GnRH antagonist protocols to standard long agonist protocols found antagonist-based approaches significantly reduced OHSS incidence without compromising pregnancy rates - one of the clearest pieces of evidence behind why protocol choice matters as much as it does.

How Gentle Stimulation Protocols Reduce OHSS Risk

This is where Hanabusa’s Japanese-inspired mini-IVF and gentle stimulation approach comes in. Rather than defaulting to a high-dose stimulation protocol for every patient, gentler protocols are built around a different philosophy:

• Lower medication doses, aiming to retrieve a smaller, higher-quality cohort of eggs rather than maximizing egg count at the expense of ovarian response control.
• Closer, more frequent monitoring during stimulation, allowing the care team to adjust medication in real time if estradiol levels or follicle growth suggest an outsized response developing.
• GnRH antagonist protocols with agonist trigger (rather than an hCG trigger) in higher-risk patients, since agonist triggers are associated with a substantially lower OHSS rate.
• Individualized dosing based on antral follicle count and ovarian reserve testing, rather than a one-size-fits-all starting dose - which is exactly the topic of the next post in this series.
• Freeze-all strategies in higher-risk cycles, delaying embryo transfer to a later frozen cycle when OHSS risk is elevated, since a fresh pregnancy can actually worsen OHSS symptoms due to rising hCG.

A 2021 study in Reproductive Biology evaluating individualized, response-tailored stimulation protocols found that adjusting medication dose based on real-time monitoring meaningfully reduced both OHSS incidence and cycle cancellation rates compared to fixed-dose approaches - supporting the case for the kind of closely monitored, individualized protocol Hanabusa builds around each patient.

Why “One Size Fits All” Doesn’t Work for Stimulation

Every patient’s ovarian reserve, hormone profile, and response history is different, which is exactly why a standardized, maximum-dose protocol is not automatically the “most effective” approach - for many patients, it is actually the approach most likely to introduce unnecessary risk without improving outcomes. A protocol calibrated to your specific ovarian reserve and monitored closely throughout stimulation is not a compromise on effectiveness; for many patients, it is the more effective and safer approach specifically because it is tailored rather than generic.

What This Means If You Are Higher Risk

If you have PCOS, a high antral follicle count, or a prior history of OHSS, this is exactly the kind of history that should shape your protocol from day one - not something addressed only after a concerning response develops mid-cycle. A thorough baseline evaluation, including ovarian reserve testing, allows your care team to build a stimulation plan around your specific risk profile from the very beginning.

Frequently Asked Questions

What are the early warning signs of OHSS?

Bloating, abdominal discomfort, nausea, and rapid weight gain during or shortly after stimulation are common early signs. Severe symptoms - significant abdominal pain, shortness of breath, or reduced urination - warrant immediate medical attention.

Does mini-IVF eliminate OHSS risk entirely?

No treatment can eliminate risk entirely, but lower-dose, gentler stimulation protocols meaningfully reduce OHSS incidence compared to high-dose approaches, particularly in patients with known risk factors.

Can OHSS affect a fresh embryo transfer?

Yes. If OHSS risk becomes elevated during stimulation, many clinics recommend a “freeze-all” approach, transferring embryos in a later frozen cycle instead, since a fresh pregnancy can worsen OHSS due to rising hCG levels.

Is OHSS more common with PCOS?

Yes, PCOS is one of the most well-established risk factors for OHSS, largely due to the higher antral follicle count typically associated with the condition.

How does Hanabusa individualize stimulation protocols?

Protocols are built around each patient’s antral follicle count, ovarian reserve testing, hormone levels, and medical history, with close monitoring throughout stimulation to adjust medication in real time if needed.

Next in This Series: The Testing That Shapes Your Protocol From Day One

Everything discussed here - dosing, monitoring, risk stratification - starts with one specific piece of diagnostic information: your antral follicle count. In the next post in this series, we break down exactly what AFC measures, what counts as normal, and what your specific number means for your protocol.